Driving stroke quality improvement at scale in EDs across a nationwide network of hospitals: strategies and interventions.


Journal

Emergency medicine journal : EMJ
ISSN: 1472-0213
Titre abrégé: Emerg Med J
Pays: England
ID NLM: 100963089

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 07 11 2018
revised: 08 04 2019
accepted: 17 04 2019
pubmed: 24 6 2019
medline: 3 1 2020
entrez: 24 6 2019
Statut: ppublish

Résumé

Reducing the treatment time while increasing the proportion of eligible stroke patients who receive intravenous tissue plasminogen activator (tPA) has been a priority for many quality improvement efforts. Recent studies have primarily focused on identifying interventions that reduce door-to-needle (DTN) time, while comparatively little has been done to determine whether these interventions also improve tPA rates. In order to investigate interventions related to process improvements, an electronic dashboard serving as a stroke performance tool was implemented to store and retrieve patient outcome data. These data were used to study the efficacy of interventions designed to facilitate triage of stroke patients in the ED, and determine the individual interventions associated with the most significant improvements in the fraction of patients receiving tPA and in reducing the DTN time. Stroke performance data from the dashboard collected over a 2-year period (2015-2017) from 89 US hospitals were analysed with respect to interventions implemented by individual facilities, as verified by a hospital survey. A statistically significant association was found between increases in the fraction of patients receiving tPA and reductions in DTN time over the study period. These improvements in outcomes were most strongly associated with process interventions that allocate stroke-specific physical and human resources in the ED, most notably a designated emergency room space for stroke, and with workflows that decrease the time to key checkpoints for determining a patient's eligibility for tPA. Data from the stroke performance tool was leveraged to identify the programmes and process interventions that lead to improved patient outcomes and allow EDs to better prioritise process interventions and resources.

Identifiants

pubmed: 31230040
pii: emermed-2018-208257
doi: 10.1136/emermed-2018-208257
doi:

Substances chimiques

Tissue Plasminogen Activator EC 3.4.21.68

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

423-430

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Max Shpak (M)

Neuroscience and Spine Institute, St. David's Medical Center, Austin, Texas, USA.
Neuroscience Division, Sarah Cannon Research Institute, Nashville, Tennessee, USA.

Kimberly Korwek (K)

Neuroscience Division, HCA Healthcare, Nashville, Tennessee, USA.

Zoltan Nadasdy (Z)

Neuroscience Division, Sarah Cannon Research Institute, Nashville, Tennessee, USA.

Anurekha Ramakrishnan (A)

Neuroscience Division, Sarah Cannon Research Institute, Nashville, Tennessee, USA.

Matthew Cowperthwaite (M)

Neuroscience and Spine Institute, St. David's Medical Center, Austin, Texas, USA.

Kristen Ankrom (K)

Neuroscience Division, HCA Healthcare, Nashville, Tennessee, USA.

Jon Jennings (J)

Neuroscience Division, HCA Healthcare, Nashville, Tennessee, USA.

Ashley Moody (A)

Neuroscience Division, HCA Healthcare, Nashville, Tennessee, USA.

Kevin Orndorff (K)

Neuroscience Division, HCA Healthcare, Nashville, Tennessee, USA.

Christopher Fanale (C)

Department of Neurosciences, HealthOne Swedish Medical Center, Denver, Colorado, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH